Bio-Rad Laboratories Inc logo

Bio-Rad Laboratories Inc - Class A

6
NYSE:BIO (USA)   Class A
$ 307.00 +2.08 (+0.68%) 11:08 PM EST
At Loss
P/B:
1.06
Volume:
238.88K
Avg Vol (2M):
284.46K
Also Trade In:
Volume:
238.88K
At Loss
Avg Vol (2M):
284.46K

Business Description

Bio-Rad Laboratories Inc logo
Bio-Rad Laboratories Inc
NAICS : 334516 SIC : 3826
ISIN : US0905722072

Share Class Description:

BIO: Class A
Description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas, Europe and Africa , and Asia-Pacific. Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Name Current Vs Industry Vs History
Cash-To-Debt 1.25
Equity-to-Asset 0.71
Debt-to-Equity 0.17
Debt-to-EBITDA 244.56
Interest Coverage 7.25
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.04
Distress
Grey
Safe
Beneish M-Score -2.41
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 57.74
9-Day RSI 54.06
14-Day RSI 49.15
6-1 Month Momentum % -25.27
12-1 Month Momentum % -33.62

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.64
Quick Ratio 4.25
Cash Ratio 3.15
Days Inventory 214.52
Days Sales Outstanding 63.71
Days Payable 40.48

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 0.4
Shareholder Yield % -2.78

Financials (Next Earnings Date:2024-02-16 Est.)

BIO's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NYSE:BIO

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Bio-Rad Laboratories Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2,720.366
EPS (TTM) ($) -5.85
Beta 0.95
Volatility % 36.63
14-Day RSI 49.15
14-Day ATR ($) 8.739486
20-Day SMA ($) 303.861
12-1 Month Momentum % -33.62
52-Week Range ($) 261.59 - 509.6225
Shares Outstanding (Mil) 29.15

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bio-Rad Laboratories Inc Filings

Filing Date Document Date Form
No Filing Data

Bio-Rad Laboratories Inc Stock Events

Event Date Price($)
No Event Data

Bio-Rad Laboratories Inc Frequently Asked Questions

What is Bio-Rad Laboratories Inc(BIO)'s stock price today?
The current price of BIO is $307.00. The 52 week high of BIO is $509.62 and 52 week low is $261.59.
When is next earnings date of Bio-Rad Laboratories Inc(BIO)?
The next earnings date of Bio-Rad Laboratories Inc(BIO) is 2024-02-16 Est..
Does Bio-Rad Laboratories Inc(BIO) pay dividends? If so, how much?
Bio-Rad Laboratories Inc(BIO) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1